Black Diamond Therapeutics (BDTX) Change in Acquisitions & Divestments: 2020-2024
Historic Change in Acquisitions & Divestments for Black Diamond Therapeutics (BDTX) over the last 5 years, with Dec 2024 value amounting to $139.8 million.
- Black Diamond Therapeutics' Change in Acquisitions & Divestments fell 33.71% to $48.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $182.8 million, marking a year-over-year change of. This contributed to the annual value of $139.8 million for FY2024, which is 78.77% up from last year.
- Black Diamond Therapeutics' Change in Acquisitions & Divestments amounted to $139.8 million in FY2024, which was up 78.77% from $78.2 million recorded in FY2023.
- Black Diamond Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $182.8 million during FY2021, with a 5-year trough of $78.2 million in FY2023.
- For the 3-year period, Black Diamond Therapeutics' Change in Acquisitions & Divestments averaged around $110.5 million, with its median value being $113.7 million (2022).
- Per our database at Business Quant, Black Diamond Therapeutics' Change in Acquisitions & Divestments skyrocketed by 101.07% in 2021 and then tumbled by 37.82% in 2022.
- Over the past 5 years, Black Diamond Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $90.9 million in 2020, then spiked by 101.07% to $182.8 million in 2021, then crashed by 37.82% to $113.7 million in 2022, then slumped by 31.24% to $78.2 million in 2023, then soared by 78.77% to $139.8 million in 2024.